The core of medicine, and medical research, is and must be the patient, and the success of future drug development will depend upon our ability to keep patients in the front of our minds and at the center of our efforts.

Fighting raging in the north of Yemen between the government and Shiite al-Houthi rebels could have a significant effect on Middle East and U.S. security, as well as on Yemen's own survival.

At The Chronicle of Higher Education, “journalistic standards” are of the double kind. And incivility is a firing offense — unless you’re criticizing a conservative, in which case nasty smears are all the rage

In the latest AEI Political Report, the AEI Politics team looks at at the new phase of 2012 campaign from a variety of angles. 

...

The most likely source of a U.S. sovereign debt crisis is a failure of the U.S. political system to address the growth of the major entitlement programs--Social Security, Medicare and Medicaid.

Yemen’s unrest has not ended with the ouster of former President Ali Abdullah Saleh. The Yemeni Revolution instead has entered a new phase, the “Parallel Revolution.”

Durably improving health is really, really hard. I've discussed this in the context of drug discovery, which must contend with the ever-more-apparent reality that biology is incredibly complex, and science remarkably fragile. Here, I'd like to focus on another challenge: measuring and improving the quality of patient care.

By keeping the focus on better health for real people, perhaps we’ll develop both the humility to recognize how little we still understand as well as the drive to ensure — and emphatically demand — that our advances ultimately wind up not only in papers, but also in patients.